Changes in Bladder Wall Thickness and Detrusor Wall Thickness After Surgical Treatment of Benign Prostatic Enlargement in Patients with Lower Urinary Tract Symptoms: a Preliminary Report
Overview
Affiliations
Purpose: The purpose of the present study was to evaluate the perioperative changes in bladder wall thickness and detrusor wall thickness after transurethral prostatectomy.
Materials And Methods: Fifty-one men who were treated for benign prostatic hyperplasia/lower urinary tract symptoms with transurethral prostatectomy were prospectively analyzed from May 2012 to July 2013. Prostate size, detrusor wall thickness, and bladder wall thickness were assessed by transrectal and transabdominal ultrasonography perioperatively. All postoperative evaluations were performed 1 month after the surgery.
Results: The patients' mean age was 69.0 years, the mean prostate-specific antigen concentration was 8.1 ng/mL, and the mean prostate volume was 63.2 mL. The mean bladder wall thickness was 5.1 mm (standard deviation [SD], ±1.6), 5.1 mm (SD, ±1.6), and 5.0 mm (SD, ±1.4) preoperatively and 4.5 mm (SD, ±1.5), 4.5 mm (SD, ±1.3), and 4.6 mm (SD, ±1.2) postoperatively in the anterior wall, dome, and trigone, respectively (p=0.178, p=0.086, and p=0.339, respectively). The mean detrusor wall thickness was 0.9 mm (SD, ±0.4) preoperatively and 0.7 mm (SD, ±0.3) postoperatively (p=0.001). A subgroup analysis stratifying patients into a large prostate group (weight, ≥45 g) and a high Abrams-Griffiths number group (>30) showed a significant decrease in detrusor wall thickness (p=0.002, p=0.018).
Conclusions: There was a decrease in detrusor wall thickness after transurethral prostatectomy. The large prostate group and the high Abrams-Griffiths number group showed a significant decrease in detrusor wall thickness after surgery.
Mei H, Wang Z, Zheng Q, Jiao P, Lv S, Liu X Neurourol Urodyn. 2025; 44(2):512-519.
PMID: 39803869 PMC: 11788940. DOI: 10.1002/nau.25665.
Recent developments in diagnostic ultrasound for lower urinary tract function.
Minagawa T J Med Ultrason (2001). 2024; .
PMID: 39327335 DOI: 10.1007/s10396-024-01494-0.
Efficiency of HoLEP in patients with detrusor underactivity and renal dysfunction secondary to BPO.
Yang D, Sun Q, Li W, Wang Y, Qian H, Li D World J Urol. 2024; 42(1):509.
PMID: 39240342 PMC: 11379783. DOI: 10.1007/s00345-024-05208-6.
Akshay A, Gheinani A, Besic M, Braga S, Uldry A, Heller M BMC Urol. 2024; 24(1):33.
PMID: 38326801 PMC: 10848355. DOI: 10.1186/s12894-024-01417-8.
[Diagnostic work-up of benign prostatic hyperplasia : The German S2e-guideline 2023 part 1].
Oelke M, Abt S, Becher K, Dreikorn K, Madersbacher S, Magistro G Urologie. 2023; 62(8):805-817.
PMID: 37401972 DOI: 10.1007/s00120-023-02142-0.